FDA issued a Warning Letter to Medaus, Inc. on 3/8/2018 for a later inspection.
483 Medaus Mar 2013

483 Medaus Mar 2013

Bruce Mccullough FDA, Meisha Waters FDA, Meisha Sampson FDA$119.00 - Available Now

FDA investigators audited the Medaus - Birmingham, AL, United States facility and issued 12 inspectional observations (via FDA 483) on 22 Mar 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 12
  • Inspection end: 22 Mar 2013
  • Location: Birmingham, United States
  • FEI: 3001298034
Add To Cart